Calcium monohydrogen phosphate, calcium ascorbate.
Each film-coated tablet contains calcium monohydrogen phosphate 500 mg and calcium ascorbate 150 mg.
Calcium monohydrogen phosphate/calcium ascorbate (Calcebone) provides a source of calcium, phosphorous and ascorbic acid, where it is desired or recommended by the physician, to increase dietary intake. This combination is necessary for the prevention and cure of deficiency diseases. With calcium monohydrogen phosphate/calcium ascorbate (Calcebone), calcium utilization is improved, and defective bone and tooth formation as well as the vitamin C deficiency, which frequently accompanies such disorder is corrected.
Used as calcium supplement during pregnancy, lactation and skeletal disorders.
1-2 tablets, 1-3 times daily or as prescribed by the physician.
Hypercalcemia and hypercalciuria. Severe renal failure.
The calcium content should be considered before prescribing to patients with kidney stones. Preparations containing tetracyclines may be impaired by oral calcium. Do not exceed the recommended dose.
Oral calcium salts can cause gastrointestinal disturbances. Excessive amounts may lead to hypercalcemia.
Hypercalcemia has occurred when calcium salts are given with thiazide diuretics or vitamin D. Vitamin D increases the gastrointestinal absorption of calcium and thiazide diuretics decrease its urinary excretion. Plasma-calcium concentrations should be monitored in patients receiving the drugs together.
Store at temperatures not exceeding 25°C.
A12AA20 - calcium (different salts in combination) ; Belongs to the class of calcium-containing preparations. Used as dietary supplements.
Calcebone FC tab
100's (P6.25/film-coated tab)
Sign Out
